Biogen (BIIB) stock powered up Friday after the firm stated the U.S. Food and Drug Administration has actually chosen to fast-track its application to bring a new Alzheimers illness drug to market.
XThe firm … [+4045 chars]
Biogen Stock Surges As FDA Fast Tracks Alzheimers Drug Application – Investors Business Daily